White Fox Ventures (AWAW) 10-Q 6 Jan 17 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Jan. 04, 2017
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,016
Entity Registrant Name	WHITE FOX VENTURES, INC.
Entity Central Index Key	1,506,503
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		73,682,959

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash	$ 57,718	$ 10,955
Investment - available for sale security	190,961	0
Prepaid expenses	190,587	52,051
Accounts receivable, net of credit card fees	181,207	0
Inventory from discontinued operations, net of reserves	0	114,067
Total current assets	620,473	177,073
Investment in Kudzoo, Inc.	50,000	0
Property and equipment, net	41,522	0
Total other assets	91,522	0
TOTAL ASSETS	711,995	177,073
CURRENT LIABILITIES
Accounts payable and accrued expenses	237,864	444,670
Notes payable - current portion	132,970	319,361
Accrued interest	3,745	17,162
Liability for stock to be issued	135,710	82,710
Notes payable - related parties	385,047	1,175,000
Liabilities of discontinued operations	239,004	232,771
Total current liabilities	1,134,339	2,271,674
Deferred revenue	573,465	0
Total other liabilities	573,465	0
TOTAL LIABILITIES	1,707,804	2,271,674
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.001 par value, 10,000,000 shares authorized Nil shares issued and outstanding	0	0
Common stock, $0.001 par value, 8,000,000,000 and 500,000,000 shares authorized, respectively 69,181,240 and 4,708,113 shares issued and outstanding, respectively	69,181	4,708
Additional paid in capital	9,436,186	7,339,096
Accumulated deficit	(10,446,674)	(9,438,405)
Accumulated other comprehensive loss	(48,186)	0
Total stockholders' equity (deficit)	(989,493)	(2,094,601)
Noncontrolling interest in subsidiary	(6,316)	0
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 711,995	$ 177,073

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value	$ .001	$ .001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ .001	$ .001
Common stock, shares authorized	8,000,000,000	500,000,000
Common stock, shares issued	69,181,240	4,708,113
Common stock, shares outstanding	69,181,240	4,708,113

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
REVENUE	$ 23,431	$ 0	$ 23,431	$ 0
COST OF GOODS SOLD	69,756	0	69,756	0
GROSS LOSS	(46,325)	0	(46,325)	0
OPERATING EXPENSES
Marketing, advertising and promotion	0	0	381,506	0
Salaries and related expenses, including stock-based compensation	0	0	5,104	0
Professional fees	194,758	302,787	380,659	4,762,594
Rent	0	0	14,836	0
Depreciation and Amortization	0	0	1,379	0
General and administrative	64,674	63,623	127,641	150,163
Total operating expenses	259,432	366,410	911,125	4,912,757
OTHER (INCOME) EXPENSE
Interest expense, net	1,193	148,600	23,084	326,274
Loss (gain) on extinguishment of debt	(116,445)	251,996	(113,624)	251,996
Other income	0	(130,000)	0	(130,000)
Gain on conversion of warrants	0	(84,577)	0	(84,577)
Fair value adjustment on derivative liability	0	0	0	60,193
Legal setlement expense	0	160,000	0	160,000
Total other (income) expense	(115,252)	346,019	(90,540)	583,886
COMBINED NET LOSS BEFORE PROVISION FOR INCOME TAXES	(190,505)	(712,429)	(866,910)	(5,496,643)
Provision for income taxes	0	0	0	0
Combined net loss from continuing operations	(190,505)	(712,429)	(866,910)	(5,496,643)
Net loss from discontinued operations	(117,403)	(326,378)	(147,675)	(2,217,944)
COMBINED NET LOSS AFTER PROVISION FOR INCOME TAXES	(307,908)	(1,038,807)	(1,014,585)	(7,714,587)
LESS NET LOSS ATTRIBUTABLE TO NON CONTROLLING INTEREST	6,316	0	6,316	0
NET LOSS ATTRIBUTABLE TO COMMON SHARES	(301,592)	(1,038,807)	(1,008,269)	(7,714,587)
Other comprehensive income (loss)
Change in unrealized loss on available for sale security	(59,039)	0	(59,039)	0
Foreign currency translation adjustment	10,853	0	10,853	0
Total other comprehensive loss	(48,186)	0	(48,186)	0
Comprehensive loss	$ (349,778)	$ (1,038,807)	$ (1,056,455)	$ (7,714,587)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	52,144,215	3,156,071	25,906,818	2,752,157
NET LOSS PER SHARE	$ (0.01)	$ (0.33)	$ (.04)	$ (2.80)

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,008,269)	$ (7,714,587)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Depreciation and amortization	1,379	25,034
Amortization of deferred financing fees	0	9,536
Non-controlling interest adjustment	(6,316)	0
Non-cash interest charges	1,383	261,612
Amortization of original issue discount	19,829	14,855
Legal fees incurred deducted from proceeds of notes payable	0	24,250
Liability for shares to be issued for legal settlement	0	160,000
Gain on warrant conversion	0	(84,577)
Gain on extinguishment of debt	(113,624)	77,243
Loss (Gain) on conversion of notes payable to common stock	(27,500)	174,752
Fair value adjustment in derivative liabilities	0	60,193
Common stock/stock options issued or to be issued for services rendered	0	5,547,305
Change in assets and liabilities
(Increase) decrease in prepaid expenses	(138,536)	(407,019)
(Increase) in accounts receivable	(181,207)	(43,481)
Deferred Revenue	573,465	0
Decrease (Increase) in inventory	114,067	(235,764)
Increase (decrease) in accounts payable and accrued expenses	(115,497)	324,259
Total adjustments	127,443	5,908,198
Net cash (used in) operating activities	(880,826)	(1,806,389)
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of fixed assets	(40,751)	0
Investment in leasehold improvements	(2,150)	0
Purchase of security - available for sale	(250,000)	0
Purchase of Investment in Kudzoo, Inc.	(50,000)	0
Net cash (used in) investing activities	(342,901)	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds received from convertible notes	0	770,250
Repayments of notes payable	(245,200)	(190,000)
Proceeds from promissory notes - related party	587,747	525,000
Proceeds to retire debt in excess of face value	0	(62,243)
Cash paid to purchase price adjustments and derivate rights on stock	0	(180,000)
Proceeds received for common stock and liability for stock to be issued	917,088	1,047,270
Net cash provided by financing activities	1,259,635	1,910,277
Foreign currency translation effect	10,855	0
NET (DECREASE) IN CASH	46,763	103,888
CASH - BEGINNING OF PERIOD	10,955	13,346
CASH - END OF PERIOD	57,718	117,234
Cash paid during the period for:
Interest	0	11,726
Income taxes	0	0
SUPPLEMENTAL NON-CASH ACTIVITY:
Issuance of common stock and warrants for prepaid expenses	0	518,200
Reverse Merger of Breathe LLC
Accumulated deficit	0	7,733,077
Prepaid expenses	0	191,584
Fixed assets	0	138,049
Mining rights	0	1,035,818
Accounts payable	0	(111,275)
Adjustment to APIC	0	9,089,658
Shares received in TAUG for commercialization of product at fair value	0	100,000
Common shares issued for investment in Tauriga	0	100,000
Original issue discount netted from convertible notes	0	58,000
Inventory purchased through issuance of common stock	0	22,500
Common shares issued for conversion of debt	186,220	406,385
Common shares issued and to be issued for conversion of related party notes payable	1,105,000	22,500
Issuance of common shares to settle accounts payable	$ 3,255	$ 0

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	The unaudited condensed consolidated financial statements included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements and notes are presented as permitted on Form 10-Q and do not contain certain information included in the Company’s annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Annual Report on Form 10-K for the year ended December 31, 2015 filed with the SEC, including the audited financial statements and the accompanying notes thereto. These unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented. On September 2, 2006, Celtic Capital, Inc. was incorporated in the State of Nevada. On October 20, 2008, Celtic Capital, Inc. changed its name to Entertainment Educational Arts Inc. On May 12, 2010, the Company changed its name to DNA Precious Metals, Inc. (the “Company”). On October 29, 2010, the Company formed DNA Canada Inc., a Canadian (Province of Quebec) incorporated company, as a wholly-owned subsidiary. The Company operated certain exploration operations through this Canadian entity. The Company acquired certain mining claims on September 9, 2011 located in the Montauban and Chavigny townships near Grondines-West in the Portneuf County of Quebec, Canada. On October 30, 2013 and November 27, 2013, the Company entered into binding agreements for the asset acquisitions of an undivided one hundred percent (100%) interest in certain mineral claims and mining assets located in the Province of Quebec’s Montauban and Chavigny townships near Grondines West, in the county of Portneuf, specifically Mining Lease BM 748 and Mining Concession Miniere CM 410. The purchase price was CDN$75,000 together with the issuance of 10,500 common shares of the Company. The common shares for the acquisition were valued at their fair market value on the day they were issued which totaled $496,860. In connection with the asset purchase, the Company also issued 400 shares of common stock to a former supplier of the vendor for mining related information of the assets purchased valued at $20,000 along with cash consideration of CDN$20,000. The transaction was approved by a bankruptcy court in Montreal, Quebec overviewing the financial restructuring of the vendor on April 17, 2014. On January 10, 2014, the Company entered into an asset purchase agreement for an undivided one hundred percent (100%) interest in certain mineral claims located in the Province of Quebec’s Montauban and Chavigny townships near Grondines West, in the county of Portneuf, including claims, rights, concessions and leases. The purchase price was CDN$70,000, 10,000 common shares of the Company and a one percent (1%) net smelter return. The Company paid CDN$10,000 upon the signing of the asset purchase agreement with the cash balance due, along with the common shares, upon the closing of the asset purchase agreement and transfer of the mineral claims in the name of the Company. The transfer of the mineral claims was completed in February 2014 whereby the remaining cash balance due and the common shares were released to the vendor. The common shares for the acquisition were valued at their fair market value on the day they were issued which totaled $340,000. The total cost of the acquisition amounted to $403,840. On April 14, 2014, the Company entered into an asset purchase agreement for an undivided one hundred percent (100%) interest in fifty-seven (57) mining claims located in the Province of Quebec’s Montauban and Chavigny townships near Grondines West, in the county of Portneuf. The purchase price was CDN$5,000 (US $4,547). On December 4, 2014, the Company presented a renewal request with the Government of the Province of Quebec to renew all 122 claims. This was granted through a decision dated February 23, 2015. On January 16, 2015, Breathe LLC, a Tennessee limited liability company, and Breathe eCigs Corp., a Tennessee corporation (“Breathe”), entered into a Share Exchange Agreement (the “Exchange Agreement”) with the Company, whereby the Company acquired all of the issued and outstanding membership interests Breathe LLC in consideration for the issuance of 1,500,000 shares of the Company’s common stock to the members of Breathe LLC. As a result of the transaction effected by the Exchange Agreement, at closing Breathe became a wholly owned subsidiary of the Company, with the former Breathe equity holders owning approximately 56% of the then issued and outstanding common stock of the Company. The Company accounted for this acquisition as a reverse merger, whereby Breathe became the accounting acquirer. As a result, the comparative figures are those of Breathe. In connection with the acquisition of Breathe LLC, on March 5, 2015 the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which the Company merged with its wholly owned subsidiary, Breathe eCig Corp. The sole purpose of the Merger was to effect a change of the Company's name from DNA Precious Metals, Inc. to Breathe eCig Corp. This name change more accurately reflected the Company’s operations at the time. With the acquisition of Breathe LLC, the Company determined to spin-off the operations of its mining operations, which were being conducted through the Company’s wholly owned subsidiary, DNA Canada, Inc. (“DNAC”). Effective February 3, 2015, the Company declared a stock dividend whereby each of the Company’s shareholders on the record date (February 3, 2015) would receive one share of DNAC for every two shares of the Company’s common stock owned. The former members of Breathe LLC tendered their shares of DNAC for redemption by the Company. With the completion of the spin-off, the Company was no longer in the mining field and its sole and exclusive business operations was the marketing of its electronic cigarettes and related vapor devices. In March 2015, the Company entered into Distribution Agreements with various distributors for the distribution of the Company’s products. On May 11, 2015, the Company formed two wholly owned subsidiaries to conduct non-eCigarette related business by way of holding medical device and other related intellectual property for the future development of for-profit activates and/or partnerships. Currently these entities are inactive, and neither holds any assets, carries any liabilities nor holds any intellectual property. On January 25, 2016, Mr. Seth M. Shaw succeeded Mr. Joshua Kimmel as Chief Executive Officer of the Company. Mr. Kimmel resigned as a director and officer of the Company at that time. On March 15, 2016, following the receipt of written consents representing a majority of its issued and outstanding shares, the Company filed an amendment to its Articles of Incorporation with the Nevada Secretary of State, increasing its authorized common stock from 500,000,000 to 8,000,000,000 shares. On April 5, 2016, Mr. Shinsuke Nakano was appointed Chief Executive Officer of the Company. Simultaneously, Mr. Shaw was appointed Interim Chief Financial Officer and Director. As of March 30, 2016, pursuant to a settlement agreement under trademark litigation with plaintiff, Breathe LLC (a Florida limited liability company, or “Breathe Florida”), the Company ceased its continuing operations in the eCigarette business. In accordance with the settlement agreement, the Company was required to pay two cash payments to Breathe Florida ($10,000 was paid on March 31, 2016 and $15,000 was paid on August 10, 2016). Under this agreement, the Company also was required to issue 500,000 restricted common shares of Company stock to Breathe Florida in addition to the transfer of 5,000,000 common shares which it held in Tauriga Sciences, Inc. At September 30, 2016 the value of the shares was $20,500 ($0.0041 per share.) The Company further agreed to split 50/50 any future sales of its held inventory. The sale of inventory was to be a joint effort by the two companies and was expected to last for one year from April 1, 2016. The Company’s management does not expect to sell the remaining inventory and has fully impaired the asset as of September 30, 2016. On April 5, 2016, the Company announced its intention to give White Fox Ventures Inc. a majority controlling interest in the Company pursuant to an Acquisition Agreement by which White Fox Ventures Inc. was to be acquired for an undetermined number of shares equating 85% of the total issued and outstanding capital of the Company. On May 23, 2016, the Company filed with the Secretary of State for the State of Nevada, the amendment to its Articles of Incorporation to change the name of the company to White Fox Ventures, Inc. (“White Fox”) to better reflect the new direction of the business and to effect a 100:1 reverse stock split. On June 17, 2016, the Company formed a subsidiary with 99% majority ownership stake. The remaining 1% of the equity in this subsidiary, White Fox Japan LLC, is held by the Company’s Chief Operating Officer and Director, Takehiro Abe, a related party. The Company currently conducts all transactional operational activity through this subsidiary, which plans, manages and promotes seminars and classes in Japan. On June 22, 2016, FINRA announced its final approval for the Company’s change of name to White Fox Ventures, Inc., as well as a 100:1 reverse stock split and the Company’s new ticker symbol, AWAW, which began trading on July 20, 2016. All share figures are shown in this report are on a post reverse split basis. Going Concern The condensed consolidated financial statements have been prepared on a going concern basis. The going concern basis of presentation assumes that the Company will continue in operation for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company has generated net losses from operations totaling $866,910 and $5,496,643 for the nine months ended September 30, 2016 and 2015, respectively. Losses from discontinued operations were $147,675 and $2,217,944 for the nine months ended September 30, 2016 and 2015, respectively. The Company’s continuation as a going concern is dependent upon, amongst other things, continued financial support from its shareholders, attaining a satisfactory revenue level, attainment of profitable operations and the generation of cash from operations and the ability to secure new financing arrangements and new capital to carry out its business plan. These matters are dependent on a number of items outside of the Company’s control and there exists material uncertainties that may cast significant doubt about the Company’s ability to continue as a going concern. On March 30, 2016, the Company discontinued the operations of its eCigarette business as a result of the settlement agreement that the Company entered into with Breathe Florida. The Company was able to convert over $1,050,000 in debt in exchange for the intellectual property of the Company in the eCig industry, and agreed to exit the industry and sell off or dispose of all remaining inventory during the next fiscal year. The Company’s management does not expect to sell the remaining inventory and has fully impaired the asset as of September 30, 2016. The Company can give no assurance that it will achieve profitability through its subsidiary in its new business of membership sales providing business seminars and classes in Japan, or be capable of sustaining profitable continuing operations. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of the carrying amounts of assets or the amount and classification of liabilities that might result if the Company is unable to continue as a going concern. These factors raise substantial doubt regarding the ability of the Company to continue as a going concern. Basis of Accounting These condensed consolidated financial statements are prepared in conformity with United States generally accepted accounting principles (“U.S. GAAP”) and are presented in U.S. dollars. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates include but are not limited to stock-based compensation and tax valuation allowances.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and Breathe as the acquisition of Breathe was accounted for as a reverse merger and Breathe is the accounting acquirer, from the effective date of the Merger between the Company and Breathe eCigs Corp. All intercompany transactions and accounts had been eliminated on consolidation. On January 16, 2015, Breathe LLC, a Tennessee limited liability company, and Breathe eCigs Corp., a Tennessee corporation (“Breathe”), entered into a Share Exchange Agreement (the “Exchange Agreement”) with the Company, whereby the Company acquired all of the issued and outstanding shares of common stock of Breathe in consideration for the issuance of 1,500,000 shares of common stock. The consolidation of Breathe eCigs Corp began January 16, 2015 through March 29, 2016 as part of continuing operations. On March 30, 2016, Breathe eCigs Corp. was moved to discontinued operations with retroactive restatement for comparative purposes. On June 17, 2016, the Company formed a subsidiary with 99% majority ownership stake. The remaining 1% of the equity in this subsidiary, White Fox Japan LLC, is held by the Company's Chief Operating Officer and Director, Takehiro Abe, a related party. The Company currently conducts all of its transactional operational activity through this subsidiary, which plans, manages and promotes seminars and classes in Japan. Consolidation of the subsidiary began with the commencement of operations upon initial funding on July 19, 2016 through the period ended September 30, 2016. Business Combination On January 16, 2015, Breathe LLC, a Tennessee limited liability company, and Breathe eCigs., a Tennessee corporation (“Breathe”) entered into the Exchange Agreement with the Company, whereby the Company acquired all of the issued and outstanding shares of common stock of Breathe in consideration for the issuance of 1,500,000 shares of common stock. This business combination was accounted for as a reverse merger whereby Breathe is the accounting acquirer, since the former Breathe shareholders then controlled greater than 50% of the voting control of the Company. Stock Based Compensation The Company estimates the fair value of stock based payment awards made to officers and directors related to the Company’s stock incentive plan, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods. The Company uses the Black-Scholes option pricing model to determine the fair value of the stock-based compensation that it grants to officers and directors. The Company is required to make certain assumptions in connection with this determination, the most important of which involves the calculation of volatility with respect to the price of its common stock. The computation of volatility is intended to produce a volatility value that is representative of the Company’s expectations about the future volatility of the price of its common stock over an expected term. Shares of the Company commenced trading on August 22, 2013. As a result, the volatility value that the Company calculated may differ from the future volatility of the price of its shares of common stock. Upon the exercise of stock options, any consideration received and the amounts previously recorded under stock-based compensation are credited to share capital. Upon the issuance of shares resulting from share awards, amounts previously recorded under stock based compensation are credited to share capital. Comprehensive Income (Loss) The Company adopted ASC 220-10, “Reporting Comprehensive Income,” (formerly SFAS No. 130). ASC 220-10 requires the reporting of comprehensive income in addition to net income from operations. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of information that historically has not been recognized in the calculation of net income. The condensed consolidated financial statements include the accounts and activities of the 99% majority owned subsidiary, White Fox Japan LLC, which is presented with a non-controlling interest of 1% for the share owned by a related party, the Company's Chief Operating Officer and Director, Takehiro Abe. The subsidiary conducts all transactional operational activity of the Company. The subsidiary will plans, manages and promotes seminars and classes in Japan. Cash and Cash Equivalents The Company considers all highly liquid debt instruments and other short-term investments (measured on the purchase date) with maturity of three months or less, when purchased, to be cash equivalents. Marketable Securities Marketable equity securities included in Investment-available for resale (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Unrealized gains or losses appear in Other Comprehensive Income (Loss). Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale. Income Taxes The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as part of the provision for income taxes in the period that includes the enactment date. Deferred tax liabilities are always provided for in full. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income. Deferred tax assets and liabilities are offset only when the Company has a right and intention to set off current tax assets and liabilities from the same taxation authority. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are expected to be realized. The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Position. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purposes of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities generally for three years after they were filed. Revenue Recognition The Company recognizes revenues from the sale of the Company’s products when the following criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is reasonably assured. Delivery occurs when goods are shipped and title and risk of loss have passed to the customer. Revenue is deferred in all instances where the earnings process is incomplete. Payments received before all the relevant criteria for revenue recognition are satisfied will be recorded as deferred revenue. Revenues and costs of revenues from consulting contracts will be recognized during the period in which the service will be performed. All revenues will be reported net of any sales discounts or taxes. Any revenues applicable to discontinued operations are included. Deferred Revenue The Company defers revenue for funds received on contracts where future value is received or could be received by the subscriber. The contracts fall into one of two categories; annual and lifetime memberships. The AWA Plus membership and the Premium membership are both annual memberships and the revenue received on these contracts are recognized pro-rata over the life of the contract or twelve months. Crest Partner and Partner memberships are lifetime memberships. Lifetime memberships are valid only when an annual membership is purchased and in good standing. The revenue on these contracts recognized over the expected duration of the contracts. In the absence of an observable duration, the Company has estimated that the duration of the contracts will be 36 months. Once an average length can be estimated the Company will reevaluate this assumption. Trade Receivables and Allowance for Doubtful Accounts The Company was engaged up until March 30, 2016 in the sales and distribution in the consumer products market through sales to distributors, wholesalers and direct to consumers via e-commerce sales of eCigarettes for use by consumers. Trade receivables consisted primarily of amounts due to the Company from its normal business activities whereby approved distributors and wholesalers were extended terms after down payments on orders. The Company controlled credit risk related to the trade receivables through credit approvals, credit limits and monitoring procedures, and performed Prepaid Expenses At times the Company pays for services, commissions, contracts or obligations under other agreements where the value of those services may extend beyond the current period. These amounts are recognized over the useful benefit period. The Company classifies amounts paid for sales commissions on contracts sold by a third party. These commissions are recognized to match the revenue recognized of the contracts. The Company also classifies costs of production of promotional content to recognize expense over the period content is in use. Inventory Finished Goods Inventory As of March 30, 2016, pursuant to a settlement agreement under trademark litigation, the Company had ceased its continuing operations in the eCigarette business. The Company agreed to split 50/50 any future sales of its held inventory with Breathe Florida. The sale of inventory is a joint effort by the two companies and shall last for one year from April 1, 2016. After such period, the Company will dispose of any remaining inventory. As a result of the settlement agreement and the discontinuance of the eCig operation, management estimated that it could sell the current inventory at $.50 for each $1 of inventory. Therefore an allowance was recorded to recognize the current expected net realizable value of the on-hand inventory. The inventory balance was $0 and $114,067 as of September 30, 2016 and December 31, 2015, respectively. This balances are reflected in inventory from discontinued operations. The Company’s management does not expect to sell the remaining inventory and has fully impaired the asset as of September 30, 2016. Loss Per Share of Common Stock Basic net loss per share (“Basic EPS”) is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted loss per share is computed by dividing adjusted net income available to common shareholders by the weighted average number of common shares outstanding adjusted for the effects of all dilutive common share issuances. Dilutive common share issuances shall be deemed to have been converted into ordinary shares at the beginning of the period. For the purpose of calculating diluted loss per share, the Company shall assume the exercise of dilutive stock options and warrants, as well as shares reserved for the conversion of certain notes payable. The assumed proceeds from these instruments shall be regarded as having been received from the issue of common shares at the average market price of common shares during the period. Dilutive common share issuances are not included in the computation of diluted loss per share when the Company reports a loss because to do so would be anti-dilutive for the periods presented. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. The accounting treatment for derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements, and at fair value as of each subsequent balance sheet date, should the characteristics of these instruments warrant the need to record the derivative liability. During the year ended December 31, 2014, as a result of entering into the convertible notes, the Company was required to classify certain non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassessed the classification at each balance sheet date. If the classification changed as a result of events during the period, the contract was reclassified as of the date of the event that caused the reclassification. The fair value of conversion options at a fixed number of shares is recorded using the intrinsic value method. Conversion options at variable rates and any options and warrants with ratchet provisions are deemed to contain a “down-round protection”. Accordingly, they do not meet the scope exception for treatment as a derivative under ASC 815 since “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock”, which is a for the scope exception as outlined under ASC 815. The Company issued convertible notes and warrants and has determined that a conversion option is embedded in the notes and it is required to bifurcate the conversion option from the host contract under ASC 815 and account for the derivatives at fair value. The estimated fair value of the conversion option was determined using the binomial model. The fair value of the conversion option was classified as a liability until the debt was converted by the note holders or paid back by the Company. The fair value was affected by changes in inputs to that model including the stock price, expected stock price volatility, the contractual term, and the risk-free interest rate. The Company continued to classify the fair value of the conversion option as a liability until the conversion option was exercised, expired or amended in a way that would no longer require these conversion options to be classified as a liability, whichever comes first. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception date. For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges as at the transaction date, April 28, 2014: Convertible Notes: April 28, 2014 September 30, 2016 Risk free interest rate 0.0577 % N/A Dividend yield N/A N/A Volatility 86.31 % N/A Warrants: April 28, 2014 September 30, 2016 Risk free interest rate 0.144 % N/A Dividend yield N/A N/A Volatility 97.33 % N/A The Company had repaid the debt associated with the derivative liability in December 2014. However, it carried the warrants through the conversion of those warrants in September 2015. As a result of the conversion of the warrants, the entire derivative liability was extinguished as of September 30, 2015. The Company has no other instruments that contain embedded derivatives. Prior to the effective date of the March 15, 2016 amendment to the Company's Articles of Incorporation increasing the authorized common shares of the Company from 500,000,000 to 8,000,000,000 shares, the Company did not have sufficient authorized shares to effectuate any conversion of convertible notes outstanding with either of the two noteholders. The Company remained in constant negotiations with the noteholders resulting in amended agreements dated March 25, 2016 and March 29, 2016, respectively, and the noteholders did not exercise their right to issue the Company a notice of default. At no time did the Company consider that the notes outstanding could not be fully settled. Upon the filing of the amendment to the Articles of Incorporation the Company in effect, cured any default under the note agreements, and as a result, no derivative liability was recorded by the Company. The amended note agreements reflect the current number of common shares needed to settle the remaining convertible note agreements and there are sufficient shares available to settle these agreements. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications had no effect on the net loss or cash flows of the Company. Restated Financial Statements Prior year amounts are presented in accordance with Amendment No. 1 to Form 10 Q/A for the quarters ended March 31, 2015 and September 30, 2015 as filed with the Securities and Exchange Commission on November 10, 2015. The required adjustments were made to properly account for the acquisition of Breathe eCigs Corp. (formerly Breathe LLC) on January 16, 2015 as a reverse merger for accounting purposes. Recently Issued Accounting Standards In February 2016, FASB issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively. Early adoption is permitted. We are currently in the process of assessing the impact the adoption of this guidance will have on the Company’s consolidated financial statements. During August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements—Going Concern.” The provisions of ASU No. 2014-15 require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company is currently assessing the impact of this ASU on the Company’s consolidated financial statements.

ACQUISITION

ACQUISITION	9 Months Ended
	Sep. 30, 2016
Business Combinations [Abstract]
ACQUISITION	Breathe eCigs Corp. Acquisition and Spin-off of DNA Canada, Inc. On January 16, 2015, Breathe eCigs Corp., a Tennessee corporation (“Breathe”), entered into a Share Exchange Agreement (the “Exchange Agreement”) with the Company, whereby the Company acquired all of the issued and outstanding shares of common stock of Breathe in consideration for the issuance of 1,500,000 shares of common stock. As a result of the transaction effected by the Exchange Agreement, at closing Breathe became a wholly owned subsidiary of the Company, with the former Breathe equity holders owning approximately 56% of the then issued and outstanding common stock of the Company. The Company accounted for this acquisition as a reverse merger, whereby Breathe became the accounting acquirer. As a result, the comparative figures are those of Breathe. With the acquisition of Breathe, management determined that it would be in the best interest of the Company and its shareholders to spin off the exploration stage mining business from the eCigarette business, in order to allow each company to focus on its principal business activity and to facilitate capital formation. The Company declared a stock dividend to its shareholders of record as of February 3, 2015 of its wholly owned subsidiary, DNA Canada, Inc. Each shareholder of record on the record date received one share of DNA Canada, Inc. for every two shares of the Company owned by the shareholder on this date. With the completion of the stock dividend, the Company no longer has an equity interest in DNA Canada, Inc. The former shareholders of Breathe participating in the stock dividend were required to tender for redemption any shares of DNA Canada, Inc. common stock received pursuant to the stock dividend in accordance with the Exchange Agreement. On March 5, 2015, the Company and Breathe entered into an Agreement and Plan of Merger pursuant to which the Company merged with its wholly owned subsidiary, Breathe. As permitted under Nevada law, the sole purpose of the Merger was to affect a change to the Company’s name from DNA Precious Metals, Inc. to Breathe eCig Corp. This change to the Amended Articles of Incorporation and name change took effect on March 11, 2015.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Sep. 30, 2016
Discontinued Operations
DISCONTINUED OPERATIONS	Trademark Settlement/Disposal of eCigarette Operations As of March 30, 2016, pursuant to a settlement agreement under trademark litigation with plaintiff, Breathe LLC (a Florida limited liability company, or “Breathe Florida”), the Company ceased its continuing operations in the eCigarette business. In accordance with the settlement agreement, the Company was required to pay two cash payments to Breathe Florida (with $10,000 paid on March 31, 2016 and $15,000 paid on August 10, 2016). Under the agreement, the Company also was required to issue 500,000 restricted common shares of Company stock in addition to the transfer of 5,000,000 common shares which it held in Tauriga Sciences, Inc. At September 30, 2016 the value of the shares was $20,500 ($0.0041 per share.) The Company transferred the shares of Tauriga Sciences, Inc. on November 2, 2016. The Company further agreed to split 50/50 any future sales of its held inventory with Breathe Florida. The sale of inventory shall be a joint effort by the two companies and shall last for a duration of one year from April 1, 2016. After such period, the Company will dispose of any remaining inventory. The Company does not expect to sell the remaining inventory and has fully impaired the asset as of September 30, 2016. As a result of the disposal of the business and the discontinuance of the eCigarette operations, the following chart reflects the results of the condensed consolidated financial statements as loss from discontinued operations as of September 30, 2016: WHITE FOX VENTURES, INC. (FORMERLY BREATHE ECIG CORP.) CONSOLIDATED STATEMENTS OF DISCOUNTED OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2015 (UNAUDITED) THREE MONTHS ENDED SEPTEMBER NINE MONTHS ENDED SEPTEMBER 2016 2015 2016 2015 REVENUE $ — $ 64,218 $ 19 $ 70,218 COST OF GOODS SOLD — 93,447 1,851 100,504 GROSS LOSS — (29,229 ) (1,832 ) (30,286 ) OPERATING EXPENSES Research and development — 10 — 2,188 Marketing, advertising and promotion — 95,930 9,000 534,163 Rent 3,561 3,561 10,683 4,748 Salaries and related expenses, including stock-based compensation — 53,660 10,911 167,810 Professional fees — 26,939 — 1,182,175 Depreciation and amortization — 12,585 — 25,034 General and administrative — 104,464 1,631 271,540 Total operating expenses 3,561 297,149 32,225 2,187,658 OTHER (INCOME) EXPENSE Loss from Inventory valuation LCM 113,842 — 113,618 — Total other (income) expense 113,842 — 113,618 — Net loss from discontinued operations $ (117,403 ) $ (326,378 ) $ (33,833 ) $ (2,217,944 ) WHITE FOX VENTURES, INC. (FORMERLY BREATHE ECIG CORP.) BALANCE SHEET FROM DISCONTINUED OPERATIONS September 30, 2016 Dcember 31, 2015 Inventory from discontinued operations, net valuation allowance $ - 114,067 Liabilities of discontinued operations $ 239,004 232,771

INVESTMENT - AVAILABLE FOR SALE

INVESTMENT - AVAILABLE FOR SALE SECURITY	9 Months Ended
	Sep. 30, 2016
Investments, Debt and Equity Securities [Abstract]
INVESTMENT - AVAILABLE FOR SALE SECURITY	On March 31, 2015, the Company received 10,869,565 common shares of Tauriga Sciences, Inc. (“TAUG”) (valued at $100,000) in exchange for 26,667 shares in connection with a commercialization/license agreement with TAUG to jointly develop a new line of business involving CBD oil cartridges on the same date. The Company shares were reflected as an investment. Due to the very low stock value of both companies and with the Company exiting the eCigarette business, both companies have impaired their respective investment to $0 as December 31, 2015. As of March 30, 2016, pursuant to the settlement agreement under trademark litigation with plaintiff, Breathe Florida, the Company was required to transfer 5,000,000 of the shares it held in Tauriga Sciences, Inc. (the transfer was done on November 2, 2016.) At September 30, 2016, the value of total shares held was $44,565 ($0.0041 per share.) On August 22, 2016 the Company entered into an agreement to invest $2,500,000 into NQ Minerals, PLC, an Australian mining company listed in London under the symbol of NQMI. Upon entering this agreement the Company invested $150,000, purchasing 1,351,351 shares. At September 30, 2016 the Company invested an additional $100,000 receiving 900,901 common shares. Effective December 1, 2016 the Company has withdrawn from its commitment to NQ Materials PLC to purchase a $2,500,000 stake in the company. At the time of the termination of this agreement the Company had invested $250,000 acquiring 2,252,252 common shares. With the withdrawal from the commitment the Company has classified the entire investment as a current asset. At September 30, 2016, the Company recorded an unrecognized loss in Other Comprehensive Income in the amount of $103,604. The loss was determined by recalculating the investment at it's fair value at September 30, 2016 and adjusting the valuation account to reflect the change in value.

CONVERTIBLE NOTES AND DERIVATIV

CONVERTIBLE NOTES AND DERIVATIVE LIABILITIES	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
CONVERTIBLE NOTES AND DERIVATIVE LIABILITIES	The following is a summary of convertible notes payable and the related derivative liabilities associated with the convertible notes payable. As a result of the reverse merger, Breathe assumed responsibility of these DNA Precious Metals, Inc. notes, and any related derivative liability that exists under these notes related to the warrant agreements. Therefore, a full discussion has been provided for clarification. On May 18, 2015, Typenex Co-Investment, LLC (“Typenex”) filed a binding arbitration against the Company in the State of Utah (the “Utah Lawsuit”) regarding a certain Warrant to purchase shares of the Company’s common stock. The Utah Lawsuit is described in more detail in Item 3 of the Company’s Annual Report for the year ended December 31, 2015 and subsequent filings. On October 13, 2015, Typenex and the Company participated in a mediation in an attempt to resolve the Utah Lawsuit without either party having to incur additional legal and court fees. As a result of the mediation and in order to resolve the Utah Lawsuit and the Arbitration and all other disputes between, on November 17, 2015 (the “Typenex Effective Date”), the Company and Typenex entered into a Settlement Agreement, Waiver and Release of Claims (the “Settlement Agreement”) and related Exchange Agreement (the “Exchange Agreement”), Pursuant to the terms of the Settlement Agreement and Exchange Agreement, the Company agreed to issue to Typenex 80,000 shares of the Company’s common shares of stock in exchanges for any rights Typenex may or may not have had under the Warrant. The Company will deliver the shares to Typenex in two installments: (i) 40,000 Shares with five trading days of the Effective Date (the “First Installment Shares”) and (ii) 40,000 Shares on or before January 1, 2016 (the “Second Installment Shares”). The First Installment Shares and the Second Installment Shares are collectively referred to herein as the Typenex Shares. Additionally, pursuant to the Settlement Agreement, beginning on January 1, 2016, Typenex had the right to put the Typenex Shares back to the Company (the “Put Right”) at the following prices: (a) for Typenex Shares put to the Company from January 1, 2016 to April 30, 2016 the price would be $1.00 per share. (b) for Typenex Shares put to the Company from May 1, 2016 to August 31, 2016 the price would be $2.00 per share. and (c) for any Typenex Shares put to Company between September 1, 2016 and December 31, 2016, the price would be $3.00 per share. Typenex had the right to put up to 6,667 Typenex Shares per month to Company (the “Monthly Put Amount”) per month. If the number of Typenex Shares put to Company in a given month was less than the Monthly Put Amount (such difference, the “Rollover Shares”), Typenex had the right to put such Typenex Shares to Company at any time in the same or immediately succeeding period. In addition to the Monthly Put Amount, Typenex also had the right to put up to 6,667 Rollover Shares per month to Company. Additionally, Typenex agreed that during any calendar week it would not sell more Typenex Shares than the greater of (i) 10% of the weekly trading volume of the Common Stock as reported on Bloomberg, L.P. or (ii) an aggregate market value of $5,000. At such time that Typenex’s Net Sales (gross proceeds of sales of the Typenex Shares sold in a minus any trading commissions or costs associated with clearing and selling such Typenex Shares minus the purchase price paid for any shares of Common Stock purchased on the open market) of Typenex Shares was equal to or greater than $200,000, Typenex’s Put Right would automatically terminate and Typenex would have no further rights to put Typenex Shares or Rollover Shares. Upon execution of the Settlement Agreement and Exchange Agreement, both parties released all claims each may have against the other relating to any other agreements to which both may be party. Under the Settlement Agreement, the Company executed a Confession of Judgment in the amount of $500,000 (the “Confession of Judgment”). In the event the Company committed a material breach of the Settlement Agreement which was not cured within five trading days, Typenex would have the right to enforce the Confession of Judgment. The Confession of Judgment, if filed as set forth above, would have carried an interest rate of 12% until paid. On March 25, 2016, the Company paid $55,000 to Typenex to settle all obligations resulting from these agreements. Convertible Note dated June 8, 2015 On June 8, 2015, the Company entered into a 12% convertible redeemable note payable with an investor. The principal amount of the note was $100,000, with net proceeds received of $96,500. The $3,500 represented legal fees. This note was to mature on June 8, 2016. The note bore interest at 12%, compounded annually. The note was convertible, in whole or in part, into shares of the Company’s common stock at a conversion price equal to the lower of closing price of the common stock on the principle market on the training day immediately preceding the closing date or 35%, of the lowest trading price of the Company’s common stock during the 20 trading days prior to conversion. Under terms of the convertible note agreement, if the closing sale price at any time fell below $5.00, then such 35% figure specified above would be reduced to 20%. The stock closing price went below $5.00 per share in the three months ended September 30, 2015. Under the convertible note agreement, the Company was required to maintain a sufficient number of shares, free from preemptive rights, to provide for the issuance of common stock upon conversion. The Company was required at all times to authorize a reserve of five times the number of shares that are actually issuable upon full conversion of this note. The Company initially instructed the transfer agent to reserve 165,000 shares of common stock for the noteholder for issuance upon conversion. The noteholder waived the requirement of the reserve shares above and beyond what was needed to convert through the maturity date, notwithstanding the initial reserve amount. At September 30, 2015 the number of shares that were issuable upon full conversion of then outstanding principal and accrued unpaid interest was 740,943, based on 20% of the lowest trading price of the Company’s common stock as reported on the OTCQB for the twenty prior trading days including the day upon which a notice of conversion is delivered ($0.70). On January 4, 2016 the Company issued 166,700 shares of common stock to the holder of the convertible note upon the noteholder's conversion of $10,002 of principal only into shares. The applicable conversion price was $0.06. Upon this conversion, the note had a remaining balance including default interest fees of $40,000. On March 29, 2016, the Company entered into an agreement with this noteholder to amend this convertible note to cure the default clause of the original agreement (no notice of default was provided). The event of default was due to the Company’s inability to reserve sufficient shares required by the convertible note agreement based on the total authorized and unissued shares, which was subsequently cured with the increase of the authorized shares to 8,000,000,000 on March 15, 2016. The holder agreed to reset the total balance due to the “Adjusted Current Balance” of $40,000. Also, under the agreement the price of future conversions would be set at $0.10. The Company was further required to reserve common shares of not less than 400,000. From the date of this agreement, the note shall not be subject to interest. On April 11, 2016, the Company issued 200,000 shares of common stock (of the 400,000) to the noteholder. The noteholder converted $2,030 of principal only for the shares. Upon this conversion, the note had a balance of $37,970. Upon the issuance of the remaining 200,000 shares, any applicable loss on conversion will be recorded at that time. As of July 15, 2016, the noteholder rendered notice of conversion to the transfer agent to convert $1,898 of outstanding principal. 1,897,700 shares were issued at a conversion rate of $0.001 (the pre-split basis). The Company believes that the stock should have been issued on a post-split basis whereby $189,770 of conversion value was transferred. The Company applied these shares towards the outstanding balance of the note of $40,000 ($0.021 per share.) There is no guarantee that the Company will be able to recover the shares or receive value from the excess shares transferred. The note balance was $0 and $50,002 as of September 30, 2016 and December 31, 2015, respectively. Convertible Note dated June 10, 2015 On June 10, 2015, the Company entered into a 12% convertible redeemable note payable with an investor. The principal amount of the note is $82,500, with net proceeds received of $75,000. The $7,500 represents an original issue discount. This note was to mature on September 10, 2016. The note bore interest at 12%, compounded annually. The note was convertible, in whole or in part, into shares of the Company’s common stock at a conversion price will be the lower of 60% of the lowest trading price of the Company’s common stock as of the date of conversion notice or $6.00 per share. As consideration for the holder’s commitment to purchase this debenture, the Company issued 6,000 shares of the Company’s common stock to the holder. In December 2015, the noteholder in three (3) separate conversions, converted $47,250 into 600,000 shares of common stock. Two of these note conversions were performed at a price below par value. The result was that $22,500 represented a discount to the common stock (which is reflected net in APIC). In March 2016, the noteholder in three (3) separate conversions converted $11,188 of principal and accrued fees into 765,000 shares of stock leaving a balance due under this note including interest and fees of $143,000. On March 25, 2016, the Company entered into an agreement with the noteholder to amend original note agreement. As part of this amendment, the Company paid $20,000 in cash to the noteholder and the noteholder agreed to reset the total balance due to the “Adjusted Current Balance” of $123,000 representing 1,230,000 shares to be issued at $0.10. The note balance was $0 and $154,188 as of September 30, 2016 and December 31, 2015, respectively. In March 2016, the noteholder in three (3) separate conversions converted $11,188 of principal and accrued fees into 765,000 shares of stock leaving a balance due under this note including interest and fees of $143,000. On March 25, 2016, the Company entered into an agreement with the noteholder to amend original note agreement. As part of this amendment, the Company paid $20,000 in cash to the noteholder and the noteholder agreed to reset the total balance due to the “Adjusted Current Balance” of $123,000 representing 1,230,000 shares to be issued at $0.10 Convertible Note dated December 23, 2015 On December 23, 2015, the Company entered into a 12% convertible redeemable note payable with an investor in the amount of $72,263. This note matures on December 23, 2016. The note bears interest at 12%, compounded annually. Any amount of principal or interest on this note which is not paid when due shall bear an interest rate of 24% per year (“default interest”.) The note may be converted, in whole or in part, into shares of the Company’s common stock. The conversion price will be the lower of 55%, equivalent to a 45% discount, of the lowest trading price of the Company’s common stock during the 20 consecutive training days immediately preceding the conversion date and the closing sale price of the common stock on the principal market on the trading day immediately preceding the closing date. If the Company's share price at any time loses the bid (ex: 0.0001 on the “ask” and zero market makers on the bid on level 2), then the conversion price may, in the holder’s sole and absolute discretion, be reduced to a fixed conversion price of $0.001 (if lower than the conversion price otherwise.) Under terms of this agreement, the Company was required to set up an initial reserve of 50,000 common shares of stock for the potential conversion of convertible note principal and interest with an additional reserve of 2,450,000 shares of common stock in the name of the holder for issuance upon conversion as soon as a sufficient number of on issued shares become authorized, no later than January 25, 2016. This amount was duly reserved with transfer agent. The Company is required to have authorized and reserved five times the number of shares that are actually issuable upon full conversion of this note. On March 29, 2016, the Company entered into an agreement with the noteholder to amend this convertible note. As a result, the Company paid $6,271 in cash to the noteholder and the noteholder agreed to reset the total balance due to the “Adjusted Current Balance” of $78,366. Also, under the agreement the price of future conversions will be set at $0.10. No shares have been issued to the noteholder subsequent to this agreement. The balance as of September 30, 2016 and December 31, 2015, was $92,000 including accumulated penalties and interest of $19,737 which was restructured as a convertible note with a fixed conversion of $0.10 with 0% annual interest. Convertible Note dated December 24, 2015 On December 24, 2015, the Company entered into an 11% convertible redeemable note payable with an investor in the amount of $43,000. This note matures on December 24, 2016. The note will also bear interest at 11%, compounded annually. Any amount of principal or interest on this note which is not paid when due shall bear an interest rate of 24% per year (“default interest”). Original issue discount was recognized on this note in the amount of $18,000. Deducted from the cash proceeds of this note were $10,000 to cover legal and miscellaneous expenses. $15,000 was paid in cash to the Company. On March 29, 2016, the Company entered into an agreement with the noteholder to amend this convertible note. As a result, the Company paid $3,729 in cash to the noteholder and the noteholder agreed to reset the total balance due to the “Adjusted Current Balance” of $46,634. Also, under the agreement the price of future conversions will be set at $0.10. The Company has not issued any shares under this agreement. The balance at September 30, 2016 and December 31, 2015 was $43,000 including $10,000 in default fees. All convertible notes payable are due within one year and are reflected as current liabilities in the condensed consolidated balance sheet at September 30, 2016. At September 30, 2016, the Company had $0 remaining in discount of the original issue discount with respect to these notes. Amortization of the original issue discount for the nine months ended September 30, 2016 and 2015 was $19,829 and $14,855. Interest expense on the convertible notes for the nine months ended September 30, 2016 and 2015 was $21,891 and $32,477, respectively. Accrued interest on these convertible notes for three months ended September 30, 2016 was $0.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' DEFICIT	Preferred Stock The Company was established on September 2, 2006 with 10,000,000 shares of preferred stock authorized with a par value of $0.001. The Company has not issued any preferred stock. Common Stock The Company was established on September 2, 2006 with 100,000,000 shares of common stock authorized with a par value of $0.001. On December 8, 2011, the Company amended the authorized stock to 150,000,000 shares. On March 17, 2014, the Company amended the authorized stock to 500,000,000 shares. On March 15, 2016, the Company’s shareholders ratified management's restructuring plan by approving the increase in authorized shares to 8,000,000,000. On May 23, 2016, the Company filed with the Secretary of State for the State of Nevada, the amendment to its Articles of Incorporation to change the name of the company to White Fox Ventures, Inc. (“White Fox”) to better reflect the new direction of the business and to effect a 100:1 reverse stock split. On May 27, 2016, the Company filed the necessary documents with FINRA requesting these items as well as requesting a new ticker symbol. On June 22, 2016, FINRA announced its final approval for the Company’s change of name to White Fox Ventures, Inc., as well as the 100:1 reverse stock split. The Company began trading under its new Ticker symbol, AWAW, on July 20, 2016. All share figures are shown in this report are on a post reverse split basis. The Company issued the following shares of common stock in 2015: On January 20, 2015 1,500,000 shares were issued in the acquisition of Breathe which was accounted for as reverse merger. On March 31, 2015, the Company issued 26,667 shares to Tauriga Sciences, Inc. (“TAUG”) in connection with a commercialization/license agreement with TAUG to jointly develop a new line of business involving CBD oil cartridges on the same date. The Company received from TAUG 10,869,565 shares of TAUG common stock (valued at $100,000) in exchange for the Company shares (reflected as an investment). Due to the very low stock value of both companies and with the Company exiting the eCigarette business, both companies have impaired their respective investment to $0 as December 31, 2015. At September 30, 2016, the value of total shares held was $44,565 ($0.0041 per share) classified as Investment – available for resale security. On May 10, 2015, the Company issued a supplier 7,500 shares of common stock at a value of $22,500 for the payment of inventory ($3.00 per share) and 3,000 shares of common stock valued at $9,000 ($3.00 per share) to a former noteholder ("Iconic") as part of an Assignment and Assumption Agreement dated May 7, 2015. 9,839 common shares were issued for cash in the amount of $1,047,270 at an average share price of $3.90. 718,588 shares of common stock for consulting services rendered and to be rendered accrued as of December 31, 2015 in the amount of $5,547,305 including the cost of 65,000 shares to be issued ($7.70 per share) including an agreement with Maxim Group LLC ("Maxim") to provide general financial advisory and investment banking services in exchange for 2.5% of the then issued and outstanding stock at the date of execution. The number of shares of common stock issued and outstanding at the time of this agreement was 2,763,527. At that date 2.5% of the issued and outstanding common stock equaled 69,088 shares. The Company, on May 18, 2015 canceled shares in the amount of 31,500 shares due to services never provided at a value of $157,500 ($5.00 per share). 850,743 common shares were issued for the conversion of principal and accrued interest by the holders of convertible notes at a value of $406,385 having and average share price of $0.50 at conversion. 171,500 common shares of stock were issued to noteholders as commitment and assignment shares and recorded as debt financing cost at a value of $176,050 (average price $1.00.) Under the first tranche of a July 2, 2015 securities purchase agreement, a single investor committed $240,000 for purchase of common stock and warrants. Net proceeds to the Company from the transaction were $233,500, with $6,500 credited to the purchaser for legal fees. The securities purchase agreement also called for a second tranche investment by the investor in the amount of $200,000, conditioned upon the effective date of a registration statement to be filed by the Company pursuant to a related registration rights agreement. The Company could terminate the second tranche in its sole discretion. The Company filed a Registration Statement on Form S-1 with the SEC on August 17, 2015. On October 2, 2015, the Company submitted a request for withdrawal of the previously filed Form S-1 pursuant to Rule 477 under the Securities Act. Under this agreement, the Company was obligated to issue 40,000 common shares of its stock at $6.00 per share subject to adjustments for stock splits, stock dividends, stock combinations and other similar transactions after the date of agreement. The final purchase price was subject to adjustment based on the closing price of the common stock on a date six months immediately following the closing date. The final purchase price was also subject to a second adjustment based on the closing price of the common stock thirty days following the first adjustment date. Under the agreement, at any time while warrants are outstanding, if the Company sold or grants any option to purchase, or sell or any common stock or common stock equivalents, at an effective price per share less than the exercise price then in effect but greater than $10.00 (price adjusted) will be considered a “dilutive issuance” and the holder of the warrant will be entitled to receive shares of common stock at an effective price per share that is less than the exercise price. The warrants issued under the agreement gave the investor the right to purchase, on a cashless basis at the investor’s election, up to 40,000 common shares at an exercise price of $20.00, subject to adjustment. At any time while warrants are outstanding, if the Company sells, or grants any option to purchase, any common stock or common stock equivalents at an effective price per share less than the exercise price then in effect but greater than $10.00 (price adjusted), the exercise price of the warrant will be adjusted downward to equal the lower price at which the common stock or common stock equivalents were sold. On August 25, 2015, the Company consented to an assignment agreement whereby the assignor received $265,000 cash in exchange for the transfer of rights pursuant to the securities purchase agreement dated July 2, 2015. As part of this agreement, the Company directly paid to the assignee $180,000 in exchange for the assignee waiving all rights under the original agreement related to price adjustments, the second tranche issuance and warrants. On September 8, 2015, warrants to purchase 6,906 common shares were exercised on a cashless basis to convert to 75,415 common shares based on a price reset to equal the conversion price associated with the debt agreements from the stated strike price of $75.00. The price reset which resulted in the conversion to 75,415 common shares was based on the difference between the market value of the stock at the time (market price of $25.00 multiplied by exercise shares of 6,906) and the exercise price ($3.75) multiplied by number of exercise shares (6,906.) This number was then divided by the adjusted price of the common stock ($1.946). As of December 31, 2015, the Company had 4,708,113 shares of common stock issued and outstanding. As of December 31, 2015 the Company had a liability of $82,710 for stock to be issued as conversion shares under the note settlement agreement of the March 13, 2015 8% convertible note. Shares were to be issued in three issuances of 5,000 not to have a value less than $5,000 each, on each of November 1, 2015, December 1, 2015 and January 1, 2016. The Company reversed liability for stock issuable under a distribution agreement in the amount of 50,000 common shares which had a value of $37,500 ($0.75 per share) due to that agreement no longer being in effect. The Company further had a liability for stock to be issued under a consulting agreement to issue 14,000 shares in the amount of $17,710 ($1.30 per share.) These shares do not include the shares owed to the noteholders as described in NOTE 5. The liability for those shares is included with the note payable balances. The Company made payments in the amount of $180,000 to buy back price adjustment rights, warrants and additional issuance rights transferred to the assignee under the original stock purchase agreement dated July 2, 2015. The Company has the 40,000 share stock certificate in its possession pending the stock reissuance to a new certificate to the assignee. The Company issued the following shares of common stock in 2016: In the nine months ended September 30, 2016, the Company issued 4,259,501 shares of common stock to holders of convertible notes. T In the nine months ended September 30, 2016, the Company issued 858,326 shares of common stock to and Peter Comito and their affiliates pursuant to the In the nine months ended September 30, 2016 In the nine months ended September 30, 2016, the Company issued 57,955,283 shares of common stock to Company board members and officers and other investors, who had invested $817,088 in the Company in the form of payment of various settlements and invoices outstanding. These investments were treated as private placements with prices ranging from $0.01 to $0.18 per share. In the nine months ended September 30, 2016, the Company issued 350,000 shares of common stock with a value of $3,255 ($0.0093 per share) along with $10,000 to settle fees due for services in the amount of $118,575. The Company recognized a gain on settlement of $115,320. On April 15, 2016, the Company issued 500,000 common shares Authorized Reserved Shares Several of the Company’s convertible notes required the Company to authorize and reserve four and in some cases five times the number of shares that were actually issuable upon full conversion of the notes (based on the conversion price of the notes in effect from time to time.) The noteholders waived the requirement of the reserve shares beyond what was needed to convert through the maturity date, notwithstanding the initial reserve amount. The Company did not have sufficient authorized and unissued common shares to convert all convertible notes, and exercise all outstanding warrants, as of December 31, 2015. However, the Company’s March 15, 2016 amendment to its Articles of Incorporation, which increased the authorized capital of the Company, cured any deficiency under these obligations. As noted herein, the noteholders had waived this requirement in anticipation of the Company’s charter amendment to increase the authorized number of common shares. Stock Options On August 12, 2013, the Company approved and adopted the 2013 Stock Incentive Plan (the “Plan”). Under the 2013 Stock Incentive Plan, the Company may grant options or share awards to its full-time employees, executive officers, directors and consultants up to a maximum of 80,000 common shares. Under the Plan, the exercise price of each option will be established at the time of grant, but may not be less than $25.00. Stock options vest as stipulated in the stock option agreement and their maximum term is 8 years. The following table summarizes information about the Company’s stock options: September 30, 2016 December 31, 2015 Weighted Weighted average average Number of exercise Number of exercise options Price options price Options outstanding, beginning of period — $ — 2,000 $ 25.00 Granted — — — — Exercised — — — Forfeited — — — Expired — $ — (2,000 ) (25.00 ) Options outstanding, end of period — — — — Under the Plan, the minimum exercise price of each option has been established at $25.00. Stock options will vest as stipulated in the stock option agreement and their max Stock options-based compensation expense included in the condensed consolidated statements of operations and comprehensive loss for the nine months ended September 30, 2016 and 2015 was $0. Warrants The following table summarizes the Company’s share warrants outstanding as of September 30, 2016 and December 31, 2015: September 30, 2016 December 31, 2015 Weighted Weighted Weighted Weighted average Average average average Number of remaining Exercise Number of remaining exercise warrants life (years) Price warrants life (years) price Warrants outstanding, beginning of year - - $ - 15,406 1.5 $ 66.00 Granted - - - - - - Exercised - - - (6,906 ) - - Expired - - - (8,500 ) - - Warrants outstanding, end of year - - $ - - - $ - On September 8, 2015, the cashless warrants to purchase 6,906 common shares were exercised to convert to 75,415 common shares based on a price reset to equal the conversion price associated with the debt agreements from the stated strike price of $75.00. The price reset which resulted in the conversion to 75,415 common shares was based on the difference between the current market value (market price of $25.00 multiplied by exercise shares of 6,906) and the exercise price ($3.75) multiplied by number of exercise shares (6,906). This number is then divided by the adjusted price of the common stock ($1.946). As of September 30, 2016, there are no warrants outstanding.

LICENSE AGREEMENT AND INVESTMEN

LICENSE AGREEMENT AND INVESTMENT	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
LICENSE AGREEMENT AND INVESTMENT	On March 31, 2015, the Company and TAUG entered into a non-exclusive license agreement, whereby TAUG would provide CBD oil cartridges to be used in the Breathe eCigs Corp. e-cigarette products. In accordance with the agreement, TAUG was to receive a royalty of 50% of the net revenues associated with the sale of certain products specified in the agreement. In addition, there was a share swap between TAUG and the Company valued at $100,000. The Company issued 26,667 shares at $3.75 for the commercialization of the products. TAUG issued 10,869,565 shares of its stock to acquire the license agreement (investment). Description Amount Stock issued $ 100,000 Total $ 100,000 Less: Management impairment valuation 100,000 Net September 30, 2016 and December 31, 2015 balances $ - Issued 26,667 shares of Company common stock 26,667 at $1.00 per share. $ 3.75 Share value $ 100,000 Less: Management impairment valuation $ 100,000 Net September 30, 2016 and December 31, 2015 balances $ - At March 30, 2016 it was determined by management of both companies that the value of the investment based on stock value and the absence of a business venture to be pursued was valueless. Therefore, the entire investment and commercialization fees recorded were written off completely. At September 30, 2016, the value of total shares held was $44,565 ($0.0041 per share) classified as Investment – available for resale security.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	On August 24, 2015, the Company received funds from 3476863 Canada Inc. (Peter Comito) in the amount of $50,000 under a Stock Purchase Agreement. The Company intended to convert these funds into equity through the issuance of common shares of stock. On March 28, 2016, the Company issued common shares under a settlement agreement to satisfy this obligation. On September 22, 2015, Giovanni Comito purchased 104,000 shares of the Company’s common stock, par value $0.10, from Joshua Kimmel, the Company’s Chief Executive Officer, Chief Financial Officer and member of the Board of Directors at the time, for an aggregate purchase price of $75,000. All such shares were “restricted securities” at the time of the purchase and will continue to be “restricted securities” as such term is defined under Rule 144 of the Securities Act of 1933, as amended. On September 22, 2015, the Company issued an unsecured promissory note to Kimmel in consideration for gross proceeds to the Company of $75,000 (constituting all proceeds received by Kimmel as part of the Comito Purchase). The Kimmel Note accrued interest at 4.5% per annum unless there were an event of default, in which case the interest rate increased to 9.0% per annum. The entire principal amount and all accrued but unpaid interest under the Kimmel Note became due and payable by the Company on September 22, 2016. As of September 30, 2016, accrued interest was $3,477. On September 30, 2015, the Company issued an unsecured promissory note to Giovanni Comito in consideration for gross proceeds to the Company of $400,000 pursuant to a letter of intent (“LOI”) purchase agreement for the sale of intellectual property held by the Company. The Giovanni Comito Note accrued interest at 4.5% per annum unless there were an event of default in which case the interest rate increased to 9.0% per annum. The entire principal amount and all accrued but unpaid interest under the Giovanni Comito Note was due and payable by the Company no later than March 31, 2016. On March 28, 2016 this obligation was satisfied as described below. During the three months ended December 31, 2015 the Company, issued nine unsecured promissory note to Peter Comito and affiliated companies in consideration for gross proceeds to the Company of $500,000 pursuant to the LOI. The Notes accrued interest at 4.5% per annum unless there were an event of default in which case the interest rate increased to 9.0% per annum. The entire principal amount and all accrued but unpaid interest under the Notes was due and payable by the Company no later than six months after issuance. On March 28, 2016 this obligation was satisfied as described below. On October 28, 2015, the Company, issued an unsecured promissory note to 9138-1095 Quebec Inc. (Angelo Chiapetta) in consideration for gross proceeds to the Company of $50,000 pursuant to the LOI. The 9138-1095 Quebec Inc. (Angelo Chiapetta) Note accruef interest at 4.5% per annum unless there were an event of default in which case the interest rate increased to 9.0% per annum. The entire principal amount and all accrued but unpaid interest under the 9138-1095 Quebec Inc. (Angelo Chiapetta) was due and payable by the Company no later than April 28, 2016. On March 28, 2016 this obligation was satisfied as described below. On November 4, 2015, the Company, issued an unsecured promissory note to 7091061 Canada Inc. (Carmine D'Argenio) in consideration for gross proceeds to the Company of $50,000 pursuant to the LOI. The 7091061 Canada Inc. (Carmine D'Argenio) Note accrued interest at 4.5% per annum unless there were an event of default in which case the interest rate increased to 9.0% per annum. The entire principal amount and all accrued but unpaid interest under the 7091061 Canada Inc. (Carmine D'Argenio) was due and payable by the Company no later than May 4, 2016. On March 28, 2016 this obligation was satisfied as described below. On March 28, 2016, the Company’s obligations under each of the Giovanni Comito Note, the nine Peter Comito Notes, the 9138-1095 Quebec Inc. (Angelo Chiapetta) Note and the 7091061 Canada Inc. (Carmine D’Argenio) Note were satisfied with the collective issuance of 858,326 shares to settle a total of $1,050,000 related party notes relating to the purchase of the Company’s intellectual property. During the three months ended March 31, 2016 a related party paid expenses and debt on behalf of the Company in the amount of $42,500 which was agreed to be settled for 550,000 shares of Company stock, issued April 4, 2016. During the nine months ended September 30, 2016 related parties funded obligations of the Company in the amount of $987,592. This amount as of November 30, 2016, was $996,667. The Company issued 52,862,002 shares of common stock to settle these obligations through November 30, 2016, with $15,618 still due. Notes Payable On August 9, 2016, the Company entered into a 12-month non-convertible note with a related party in the amount of $25,000 bearing an interest rate of 8%. The note matures on August 9, 2017. If the note defaults, the lender at its discretion may convert principal and accrued interest into common stock at a value of $0.01 per share.

PROVISION FOR INCOME TAXES

PROVISION FOR INCOME TAXES	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
PROVISION FOR INCOME TAXES	As of September 30, 2016, there is no provision for income taxes, current or deferred. Net operating losses carryforward $ 1,567,001 Valuation allowance (1,567,001 ) $ - The Company has approximately $10,446,674 in net operating losses as of September 30, 2016 available to offset future taxable income through 2036. The Company has established a valuation allowance equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods. A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and the statutory rate for year ended September 30, 2016 is summarized below: Federal rate 15 % State rate - % Combined Tax Rate 15 % Valuation allowance (15 )%

COMMITMENTS

COMMITMENTS	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	The Company had the following financial commitments, represented by lease agreements, as of September 30 2016, Year ending December 31, 2016 $ 26,241 2017 103,271 2018 50,013 $ 179,241 Rent expense for the three and nine months ended September 30, 2016 was $25,519 and $21,958 compared to $3,561 and $4,748 for the same period in the prior year. Rental amounts are presented in both continuing and discontinued operations. On March 15, 2015 the Company entered into a 38-month lease agreement for office space 322 Nancy Lane, Suite 7, Knoxville, Tennessee. This office was the former operational headquarters for the Company. The Company is currently working with the landlord to find another tenant for this space and remove this obligation. On April 25, 2016 the Company entered into a lease agreement for virtual office space on New York City, New York to conduct Company business and investor relations. Rent payments commenced on May 1, 2016. The total commitment is $2,790 with an expiration of April 30, 2016. On September 20, 2016, White Fox Japan LLC, the Company’s majority owned subsidiary entered into an approximately two-year lease for office space. The lease commenced on August 1, 2016, expiring September 19, 2018. Rent is fixed over the lease period at $7,300 per month.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Corporate Matters On October 17, 2016, the Company’s CEO, Shinsuke Nakano repurchased from former Chief Financial Officer, Seth Shaw, 3,200,000 shares at price of $0.01 for a total value of $32,000. On November 2, 2016, the Company transferred the 5,000,000 common shares which it holds in Tauriga Sciences, Inc. pursuant to the March 30, 2016 settlement agreement under trademark litigation with Breathe LLC (a Florida limited liability company.) At the time of the transfer, the shares had a fair market value of $36,500 ($0.0073.) Effective December 1, 2016 the Company has withdrawn from its commitment to NQ Materials PLC to purchase a $2,500,000 stake in the company. At the time of the termination of this agreement the Company had invested $250,000 acquiring 2,252,252 common shares. Stock Issuances On October 18, 2016, the Company issued 4,501,719 common shares valued at $112,543 ($0.025 per share) to Chief Executive Officer, Shinsuke Nakano, as repayment of funds used to fund consultants in the areas of legal, administration, web design and accounting as well as a $100,000 investment in NQ Materials PLC representing the second tranche of the investment. These shares were recorded as a private placement sale of common shares.

SUMMARY OF SIGNIFICANT ACCOUN18

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Basis of Accounting	These condensed consolidated financial statements are prepared in conformity with United States generally accepted accounting principles (“U.S. GAAP”) and are presented in U.S. dollars.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates include but are not limited to stock-based compensation and tax valuation allowances.
Principles of Consolidation	The condensed consolidated financial statements include the accounts of the Company and Breathe as the acquisition of Breathe was accounted for as a reverse merger and Breathe is the accounting acquirer, from the effective date of the Merger between the Company and Breathe eCigs Corp. All intercompany transactions and accounts had been eliminated on consolidation. On January 16, 2015, Breathe LLC, a Tennessee limited liability company, and Breathe eCigs Corp., a Tennessee corporation (“Breathe”), entered into a Share Exchange Agreement (the “Exchange Agreement”) with the Company, whereby the Company acquired all of the issued and outstanding shares of common stock of Breathe in consideration for the issuance of 1,500,000 shares of common stock. The consolidation of Breathe eCigs Corp began January 16, 2015 through March 29, 2016 as part of continuing operations. On March 30, 2016, Breathe eCigs Corp was moved to discontinued operations with retroactive restatement for comparative purposes. On June 17, 2016, the Company formed a subsidiary with 99% majority ownership stake. The remaining 1% of the equity in this subsidiary, White Fox Japan LLC, is held by the Company's Chief Operating Officer and Director, Takehiro Abe, a related party. The Company currently conducts all of its transactional operational activity through this subsidiary, which plans, manages and promotes seminars and classes in Japan. Consolidation of the subsidiary began with the commencement of operations upon initial funding on July 19, 2016 through the period ended September 30, 2016.
Business Combination	On January 16, 2015, Breathe LLC, a Tennessee limited liability company, and Breathe eCigs., a Tennessee corporation (“Breathe”) entered into the Exchange Agreement with the Company, whereby the Company acquired all of the issued and outstanding shares of common stock of Breathe in consideration for the issuance of 1,500,000 shares of common stock. This business combination was accounted for as a reverse merger whereby Breathe is the accounting acquirer, since the former Breathe shareholders then controlled greater than 50% of the voting control of the Company.
Stock Based Compensation	The Company estimates the fair value of stock based payment awards made to officers and directors related to the Company’s stock incentive plan, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods. The Company uses the Black-Scholes option pricing model to determine the fair value of the stock-based compensation that it grants to officers and directors. The Company is required to make certain assumptions in connection with this determination, the most important of which involves the calculation of volatility with respect to the price of its common stock. The computation of volatility is intended to produce a volatility value that is representative of the Company’s expectations about the future volatility of the price of its common stock over an expected term. Shares of the Company commenced trading on August 22, 2013. As a result, the volatility value that the Company calculated may differ from the future volatility of the price of its shares of common stock. Upon the exercise of stock options, any consideration received and the amounts previously recorded under stock-based compensation are credited to share capital. Upon the issuance of shares resulting from share awards, amounts previously recorded under stock based compensation are credited to share capital.
Comprehensive Income (Loss)	The Company adopted ASC 220-10, “Reporting Comprehensive Income,” (formerly SFAS No. 130). ASC 220-10 requires the reporting of comprehensive income in addition to net income from operations. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of information that historically has not been recognized in the calculation of net income. The condensed consolidated financial statements include the accounts and activities of the 99% majority owned subsidiary, White Fox Japan LLC, which is presented with a non-controlling interest of 1% for the share owned by a related party, the Company's Chief Operating Officer and Director, Takehiro Abe. The subsidiary conducts all transactional operational activity of the Company. The subsidiary will plans, manages and promotes seminars and classes in Japan.
Cash and Cash Equivalents	The Company considers all highly liquid debt instruments and other short-term investments (measured on the purchase date) with maturity of three months or less, when purchased, to be cash equivalents.
Marketable Securities	Marketable equity securities included in Investment-available for resale (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Unrealized gains or losses appear in Other Comprehensive Income (Loss). Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.
Income Taxes	The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as part of the provision for income taxes in the period that includes the enactment date. Deferred tax liabilities are always provided for in full. Deferred tax assets are recognized to the extent that it is probable that they will be able to be utilized against future taxable income. Deferred tax assets and liabilities are offset only when the Company has a right and intention to set off current tax assets and liabilities from the same taxation authority. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are expected to be realized. The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Position. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more likely than not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purposes of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities generally for three years after they were filed.
Deferred Revenue	The Company defers revenue for funds received on contracts where future value is received or could be received by the subscriber. The contracts fall into one of two categories; annual and lifetime memberships. The AWA Plus membership and the Premium membership are both annual memberships and the revenue received on these contracts are recognized pro-rata over the life of the contract or twelve months. Crest Partner and Partner memberships are lifetime memberships. Lifetime memberships are valid only when an annual membership is purchased and in good standing. The revenue on these contracts recognized over the expected duration of the contracts. In the absence of an observable duration, the Company has estimated that the duration of the contracts will be 36 months. Once an average length can be estimated the Company will reevaluate this assumption.
Revenue Recognition	The Company recognizes revenues from the sale of the Company’s products when the following criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is reasonably assured. Delivery occurs when goods are shipped and title and risk of loss have passed to the customer. Revenue is deferred in all instances where the earnings process is incomplete. Payments received before all the relevant criteria for revenue recognition are satisfied will be recorded as deferred revenue. Revenues and costs of revenues from consulting contracts will be recognized during the period in which the service will be performed. All revenues will be reported net of any sales discounts or taxes. Any revenues applicable to discontinued operations are included.
Trade Receivables and Allowance for Doubtful Accounts	The Company was engaged up until March 30, 2016 in the sales and distribution in the consumer products market through sales to distributors, wholesalers and direct to consumers via e-commerce sales of eCigarettes for use by consumers. Trade receivables consisted primarily of amounts due to the Company from its normal business activities whereby approved distributors and wholesalers were extended terms after down payments on orders. The Company controlled credit risk related to the trade receivables through credit approvals, credit limits and monitoring procedures, and performed ongoing credit evaluations of the customers. In assessing the carrying value of its trade receivables, the Company estimated the recoverability by making assumptions based on factors such as current overall and industry-specific economic conditions, historical and anticipated customer performance, historical write-off and collection experience, the level of past-due amounts, and specific risks identified in the accounts receivable portfolio. Additional changes to the allowance could be necessary in the future if a customer’s creditworthiness deteriorates, or if actual defaults are higher than the Company’s historical experience. Any difference could result in an increase or decrease in the allowance for doubtful accounts. All accounts receivable, net of an allowance are considered uncollectable and have a carrying value of $0 in light of the discontinuance of operations in the consumer products market.
Prepaid expenses	At times the Company pays for services, commissions, contracts or obligations under other agreements where the value of those services may extend beyond the current period. These amounts are recognized over the useful benefit period. The Company classifies amounts paid for sales commissions on contracts sold by a third party. These commissions are recognized to match the revenue recognized of the contracts. The Company also classifies costs of production of promotional content to recognize expense over the period content is in use.
Receivable - other
Inventory	Finished Goods Inventory As of March 30, 2016, pursuant to a settlement agreement under trademark litigation, the Company had ceased its continuing operations in the eCigarette business. The Company agreed to split 50/50 any future sales of its held inventory with Breathe Florida. The sale of inventory is a joint effort by the two companies and shall last for one year from April 1, 2016. After such period, the Company will dispose of any remaining inventory. As a result of the settlement agreement and the discontinuance of the eCig operation, management estimated that it could sell the current inventory at $.50 for each $1 of inventory. Therefore an allowance was recorded to recognize the current expected net realizable value of the on-hand inventory. The inventory balance was $0 and $114,067 as of September 30, 2016 and December 31, 2015, respectively. This balances are reflected in inventory from discontinued operations. The Company’s management does not expect to sell the remaining inventory and has fully impaired the asset as of September 30, 2016.
Loss Per Share of Common Stock	Basic net loss per share (“Basic EPS”) is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted loss per share is computed by dividing adjusted net income available to common shareholders by the weighted average number of common shares outstanding adjusted for the effects of all dilutive common share issuances. Dilutive common share issuances shall be deemed to have been converted into ordinary shares at the beginning of the period. For the purpose of calculating diluted loss per share, the Company shall assume the exercise of dilutive stock options and warrants, as well as shares reserved for the conversion of certain notes payable. The assumed proceeds from these instruments shall be regarded as having been received from the issue of common shares at the average market price of common shares during the period. Dilutive common share issuances are not included in the computation of diluted loss per share when the Company reports a loss because to do so would be anti-dilutive for the periods presented.
Derivative Financial Instruments	The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. The accounting treatment for derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements, and at fair value as of each subsequent balance sheet date, should the characteristics of these instruments warrant the need to record the derivative liability. During the year ended December 31, 2014, as a result of entering into the convertible notes, the Company was required to classify certain non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date. The Company reassessed the classification at each balance sheet date. If the classification changed as a result of events during the period, the contract was reclassified as of the date of the event that caused the reclassification. The fair value of conversion options at a fixed number of shares is recorded using the intrinsic value method. Conversion options at variable rates and any options and warrants with ratchet provisions are deemed to contain a “down-round protection”. Accordingly, they do not meet the scope exception for treatment as a derivative under ASC 815 since “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock”, which is a for the scope exception as outlined under ASC 815. The Company issued convertible notes and warrants and has determined that a conversion option is embedded in the notes and it is required to bifurcate the conversion option from the host contract under ASC 815 and account for the derivatives at fair value. The estimated fair value of the conversion option was determined using the binomial model. The fair value of the conversion option was classified as a liability until the debt was converted by the note holders or paid back by the Company. The fair value was affected by changes in inputs to that model including the stock price, expected stock price volatility, the contractual term, and the risk-free interest rate. The Company continued to classify the fair value of the conversion option as a liability until the conversion option was exercised, expired or amended in a way that would no longer require these conversion options to be classified as a liability, whichever comes first. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception date. For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges as at the transaction date, April 28, 2014: Convertible Notes: April 28, 2014 September 30, 2016 Risk free interest rate 0.0577 % N/A Dividend yield N/A N/A Volatility 86.31 % N/A Warrants: April 28, 2014 September 30, 2016 Risk free interest rate 0.144 % N/A Dividend yield N/A N/A Volatility 97.33 % N/A The Company had repaid the debt associated with the derivative liability in December 2014. However, it carried the warrants through the conversion of those warrants in September 2015. As a result of the conversion of the warrants, the entire derivative liability was extinguished as of September 30, 2015. The Company has no other instruments that contain embedded derivatives. Prior to the effective date of the March 15, 2016 amendment to the Company's Articles of Incorporation increasing the authorized common shares of the Company from 500,000,000 to 8,000,000,000 shares, the Company did not have sufficient authorized shares to effectuate any conversion of convertible notes outstanding with either of the two noteholders. The Company remained in constant negotiations with the noteholders resulting in amended agreements dated March 25, 2016 and March 29, 2016, respectively, and the noteholders did not exercise their right to issue the Company a notice of default. At no time did the Company consider that the notes outstanding could not be fully settled. Upon the filing of the amendment to the Articles of Incorporation the Company in effect, cured any default under the note agreements, and as a result, no derivative liability was recorded by the Company. The amended note agreements reflect the current number of common shares needed to settle the remaining convertible note agreements and there are sufficient shares available to settle these agreements.
Foreign Currency Translation	The Company translates the foreign currency of its majority owned subsidiary. The subsidiary, White Fox Japan LLC, functional currency is Japanese Yen. The financial statements are translated into US Dollars using the year or reporting period end exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at weighted average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity (deficit). Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited condensed consolidated results of operations.
Reclassifications	Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications had no effect on the net loss or cash flows of the Company.
Restated Financial Statements	Prior year amounts are presented in accordance with Amendment No. 1 to Form 10 Q/A for the quarters ended March 31, 2015 and September 30, 2015 as filed with the Securities and Exchange Commission on November 10, 2015. The required adjustments were made to properly account for the acquisition of Breathe eCigs Corp. (formerly Breathe LLC) on January 16, 2015 as a reverse merger for accounting purposes.
Recent Issued Accounting Standards	In February 2016, FASB issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively. Early adoption is permitted. We are currently in the process of assessing the impact the adoption of this guidance will have on the Company’s consolidated financial statements. During August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements—Going Concern.” The provisions of ASU No. 2014-15 require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this ASU are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company is currently assessing the impact of this ASU on the Company’s consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN19

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Schedule of Assumptions Used	Convertible Notes: April 28, 2014 September 30, 2016 Risk free interest rate 0.0577 % N/A Dividend yield N/A N/A Volatility 86.31 % N/A Warrants: April 28, 2014 September 30, 2016 Risk free interest rate 0.144 % N/A Dividend yield N/A N/A Volatility 97.33 % N/A

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Sep. 30, 2016
Discontinued Operations Tables
Discontinued operations	THREE MONTHS ENDED SEPTEMBER NINE MONTHS ENDED SEPTEMBER 2016 2015 2016 2015 REVENUE $ — $ 64,218 $ 19 $ 70,218 COST OF GOODS SOLD — 93,447 1,851 100,504 GROSS LOSS — (29,229 ) (1,832 ) (30,286 ) OPERATING EXPENSES Research and development — 10 — 2,188 Marketing, advertising and promotion — 95,930 9,000 534,163 Rent 3,561 3,561 10,683 4,748 Salaries and related expenses, including stock-based compensation — 53,660 10,911 167,810 Professional fees — 26,939 — 1,182,175 Depreciation and amortization — 12,585 — 25,034 General and administrative — 104,464 1,631 271,540 Total operating expenses 3,561 297,149 32,225 2,187,658 OTHER (INCOME) EXPENSE Loss from Inventory valuation LCM 113,842 — 113,618 — Total other (income) expense 113,842 — 113,618 — Net loss from discontinued operations $ (117,403 ) $ (326,378 ) $ (33,833 ) $ (2,217,944 ) September 30, 2016 Dcember 31, 2015 Inventory of discontinued operations, net of valuation allowance $ - 114,067 Liabilities of discontinued operations $ 239,004 232,771

STOCKHOLDERS' DEFICIT (Tables)

STOCKHOLDERS' DEFICIT (Tables)	9 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
Schedule of Stock Option Activity	September 30, 2016 December 31, 2015 Weighted Weighted average average Number of exercise Number of exercise options Price options price Options outstanding, beginning of period — $ — 2,000 $ 25.00 Granted — — — — Exercised — — — Forfeited — — — Expired — $ — (2,000 ) (25.00 ) Options outstanding, end of period — — — —
Schedule of Warrant Activity	September 30, 2016 December 31, 2015 Weighted Weighted Weighted Weighted average Average average average Number of remaining Exercise Number of remaining exercise warrants life (years) Price warrants life (years) price Warrants outstanding, beginning of year - - $ - 15,406 1.5 $ 66.00 Granted - - - - - - Exercised - - - (6,906 ) - - Expired - - - (8,500 ) - - Warrants outstanding, end of year - - $ - - - $ -

LICENSE AGREEMENT AND INVESTM22

LICENSE AGREEMENT AND INVESTMENT (Tables)	9 Months Ended
	Sep. 30, 2016
License Agreement And Investment Tables
License agreement and investment	Description Amount Stock issued $ 100,000 Total $ 100,000 Less: Management impairment valuation 100,000 Net September 30, 2016 and December 31, 2015 balances $ - Issued 26,667 shares of Company common stock 26,667 at $1.00 per share. $ 3.75 Share value $ 100,000 Less: Management impairment valuation $ 100,000 Net September 30, 2016 and December 31, 2015 balances $ -

PROVISION FOR INCOME TAXES (Tab

PROVISION FOR INCOME TAXES (Tables)	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Schedule of Components of Provision for Income Taxes	Net operating losses carryforward $ 1,567,001 Valuation allowance (1,567,001 ) $ -
Reconciliation of Effective Tax Rate as a Percentage of Income Before Taxes and Federal Statutory Rate	Federal rate 15 % State rate - % Combined Tax Rate 15 % Valuation allowance (15 )%

COMMITMENTS (Tables)

COMMITMENTS (Tables)	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Leases	Year ending December 31, 2016 $ 26,241 2017 103,271 2018 50,013 $ 179,241

ORGANIZATION AND BASIS OF PRE25

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss			$ (1,008,269)	$ (7,714,587)
Proceeds from related party debt			587,747	525,000
Proceeds from promissory notes - related party			587,747	525,000
Common shares issued for conversion of debt			186,220	406,385
Losses from discontinued operations	$ (117,403)	$ (326,378)	(147,675)	(2,217,944)
Combined net loss from continuing operations	$ (190,505)	$ (712,429)	$ (866,910)	$ (5,496,643)

SUMMARY OF SIGNIFICANT ACCOUN26

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	4 Months Ended	9 Months Ended
	Apr. 28, 2014	Sep. 30, 2016
Warrant [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk free interest rate	0.14%
Dividend yield
Expected volatility	97.33%
Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk free interest rate	0.0577%
Dividend yield
Expected volatility	86.31%

ACQUISITION (Details Narrative)

ACQUISITION (Details Narrative)	9 Months Ended
	Sep. 30, 2016shares
Business Combinations [Abstract]
Acquisition date	Jan. 16, 2016
Issuance of shares for acquisition	1,500,000

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Discontinued Operations Details
REVENUE	$ 0	$ 64,218	$ 19	$ 70,218
COST OF GOODS SOLD	0	93,447	1,851	100,504
GROSS LOSS	0	(29,229)	(1,832)	(30,286)
OPERATING EXPENSES
Research and development	0	10	0	2,188
Marketing, advertising and promotion	0	95,930	9,000	534,163
Rent	3,561	3,561	10,683	4,748
Salaries and related expenses, including stock-based compensation	0	53,660	10,911	167,810
Professional fees	0	26,939	0	1,182,175
Depreciation and amortization	0	12,585	0	25,034
General and administrative	0	104,464	1,631	271,540
Total operating expenses	3,561	297,149	32,225	2,187,658
OTHER (INCOME) EXPENSE
Loss from Inventory valuation LCM	113,842	0	113,618	0
Total other (income) expense	113,842	0	113,618	0
Net loss from discontinued operations	$ (117,403)	$ (326,378)	$ (147,675)	$ (2,217,944)

DISCONTINUED OPERATIONS (Deta29

DISCONTINUED OPERATIONS (Details 1) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Discontinued Operations Details 1
Inventory from discontinued operations, net valuation allowance		$ 114,067
Liabilities of discontinued operations	$ 239,004	$ 232,771

INVESTMENT - AVAILABLE FOR SA30

INVESTMENT - AVAILABLE FOR SALE SECURITY (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Equity investment agreement amount			$ 2,500,000
Payment for marketable securities			$ 250,000
Shares purchased for equity investment			2,252,252
Loss (gain) on conversion of debt	$ (116,445)	$ 251,996	$ (113,624)	$ 251,996
Availableforsale Securities [Member]
Payment for marketable securities			$ 150,000
Shares purchased for equity investment			1,351,351
Availableforsale Securities 2 [Member]
Payment for marketable securities			$ 250,000
Shares purchased for equity investment			900,901

CONVERTIBLE NOTES AND DERIVAT31

CONVERTIBLE NOTES AND DERIVATIVE LIABILITIES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Debt Instrument [Line Items]
Amortization of original issue discount	$ 19,829	$ 14,855

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Warrant [Member]
Number of options:
Outstanding, beginning of period	0	15,406
Granted	0	0
Exercised	0	(6,906)
Expired	0	(8,500)
Outstanding, end of period	0	0
Weighted average exercisable price:
Outstanding, beginning of period	$ 0	$ 66
Granted	0	0
Exercised	0	0
Forfeited	0
Expired		0
Outstanding, end of period	$ 0	$ 0
Stock Option [Member]
Number of options:
Outstanding, beginning of period	0	2,000
Granted	0	0
Exercised	0	0
Forfeited	0	0
Expired	0	(2,000)
Outstanding, end of period	0	0
Weighted average exercisable price:
Outstanding, beginning of period	$ 0	$ 25
Granted	0	0
Exercised	0	0
Forfeited	0	0
Expired	0	(25)
Outstanding, end of period	$ 0	$ 0

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details 1) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Warrant [Member]
Number of warrants
Outstanding, beginning of period	0	15,406
Granted	0	0
Exercised	0	(6,906)
Expired	0	(8,500)
Outstanding, end of period	0	0
Weighted average remaining life (years)
Outstanding, beginning of period		1 year 6 months
Outstanding, end of period		0 years
Weighted average exercise price:
Outstanding, beginning of period	$ 0	$ 66
Granted	0	0
Exercised	0	0
Expired		0
Outstanding, end of period	$ 0	$ 0
Stock Option [Member]
Number of warrants
Outstanding, beginning of period	0	2,000
Granted	0	0
Exercised	0	0
Expired	0	(2,000)
Outstanding, end of period	0	0
Weighted average exercise price:
Outstanding, beginning of period	$ 0	$ 25
Granted	0	0
Exercised	0	0
Expired	0	25
Outstanding, end of period	$ 0	$ 0

STOCKHOLDERS' DEFICIT (Detail34

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Common stock, outstanding	69,181,240		4,708,113
Stock options-based compensation expense	$ 0	$ 0
Stock Option [Member]
Outstanding, end of period	0		0	2,000
Warrant [Member]
Outstanding, end of period	0		0	15,406

LICENSE AGREEMENT AND INVESTM35

LICENSE AGREEMENT AND INVESTMENT (Details) - License agreement [Member] - USD ($)	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
License Agreement / Commercialization Fees - 2 years dated 3/31/15
Stock issued	$ 100,000
Total	100,000
Less: Management impairment valuation	(100,000)
Net end of reporting period	$ 0	$ 0
Issued 26,667 shares of Company common stock	26,667
at $0.01 per share.	$ 3.75
Share value	$ 100,000
Less: Management impairment valuation	$ 100,000
Net end of reporting period		$ 0

LICENSE AGREEMENT AND INVESTM36

LICENSE AGREEMENT AND INVESTMENT (Details Narrative) - License agreement [Member]	9 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares
Royalty rate	50.00%
Stock issued | $	$ 100,000
Issued shares of Company common stock	26,667
Price of shares issued | $ / shares	$ 3.75
Shares received for royalty agreement	10,869,565

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	9 Months Ended
	Sep. 30, 2016USD ($)
Obligations [Member]
Related party debt	$ 987,592

PROVISION FOR INCOME TAXES (Det

PROVISION FOR INCOME TAXES (Details)	Sep. 30, 2016USD ($)
Provision For Income Taxes Details
Net operating losses carryforward	$ 1,567,001
Valuation allowance	(1,567,001)
Total	$ 0

PROVISION FOR INCOME TAXES (D39

PROVISION FOR INCOME TAXES (Details 1)	9 Months Ended
	Sep. 30, 2016
Provision For Income Taxes Details 1
Federal rate	15.00%
State rate	0.00%
Combined Tax Rate	15.00%
Valuation allowance	(15.00%)

COMMITMENTS (Details)

COMMITMENTS (Details)	Sep. 30, 2016USD ($)
Year ending December 31,
2,016	$ 26,241
2,017	103,271
2,018	50,013
Total	$ 179,241

COMMITMENTS (Details Narrative)

COMMITMENTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 25,519	$ 3,561	$ 21,958	$ 4,748